Cutler Group LP Tg Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	SELL	$13.02 - $21.3 $1,302 - $2,130	-100 Reduced 3.23%	3,000 $0
Q3 2023 Nov 07, 2023	BUY	$8.36 - $26.5 $25,080 - $79,500	3,000 Added 3000.0%	3,100 $36,000
Q1 2023 May 01, 2023	SELL	$10.23 - $19.34 $131,967 - $249,486	-12,900 Reduced 99.23%	100 $0
Q4 2022 Feb 07, 2023	BUY	$5.01 - $11.83 $64,629 - $152,607	12,900 Added 12900.0%	13,000 $4,000
Q3 2022 Oct 25, 2022	SELL	$4.57 - $8.4 $13,710 - $25,200	-3,000 Reduced 96.77%	100 $1,000
Q2 2022 Aug 04, 2022	SELL	$3.74 - $10.66 $20,944 - $59,696	-5,600 Reduced 64.37%	3,100 $6,000
Q1 2022 Apr 14, 2022	BUY	$7.81 - $20.45 $35,145 - $92,025	4,500 Added 107.14%	8,700 $39,000
Q4 2021 Jan 18, 2022	SELL	$15.2 - $35.51 $13,680 - $31,959	-900 Reduced 17.65%	4,200 $31,000
Q2 2021 Jul 19, 2021	BUY	$32.5 - $48.96 $87,750 - $132,192	2,700 Added 112.5%	5,100 $18,000
Q1 2021 Apr 26, 2021	SELL	$41.61 - $54.3 $299,592 - $390,960	-7,200 Reduced 75.0%	2,400 $11,000
Q4 2020 Jan 21, 2021	BUY	$25.27 - $54.9 $116,242 - $252,540	4,600 Added 92.0%	9,600 $12,000
Q3 2020 Oct 27, 2020	SELL	$18.49 - $27.24 $46,224 - $68,100	-2,500 Reduced 33.33%	5,000 $10,000
Q2 2020 Jul 22, 2020	BUY	$8.9 - $21.84 $48,950 - $120,120	5,500 Added 275.0%	7,500 $13,000
Q4 2018 Feb 05, 2019	SELL	$3.44 - $5.76 $26,488 - $44,352	-7,700 Reduced 79.38%	2,000 $2,000
Q3 2018 Nov 07, 2018	BUY	$5.15 - $14.0 $44,290 - $120,400	8,600 Added 781.82%	9,700 $42,000
Q1 2018 May 11, 2018	SELL	$8.7 - $16.8 $1,739 - $3,360	-200 Reduced 15.38%	1,100 $0
Q4 2017 Jan 17, 2018	SELL	$7.35 - $12.3 $5,880 - $9,840	-800 Reduced 38.1%	1,300 $1,000
Q3 2017 Oct 17, 2017	BUY	$10.0 - $12.7 $21,000 - $26,670	2,100	2,100 $1,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$455 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$336 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$269 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$106 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$94.7 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account